Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Benjamin Waschki (Hamburg, Germany), Benjamin Waschki, Anne Kirsten, Olaf Holz, Thorsten Meyer, Ralf Lichtinghagen, Klaus Rabe, Helgo Magnussen, Tobias Welte, Henrik Watz, Sabina Janciauskiene. Association of angiopoietin-like protein 4 with cardiovascular function in patients with COPD. Eur Respir J 2016; 48: Suppl. 60, 3004

Member's Comments

No comment yet.

Related content which might interest you: Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD Source: International Congress 2014 – Predictors Year: 2014 Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Metabolic regulation during the co-existence of COPD and DM type2 Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Microalbuminuria as a cardiovascular biomarker in patients with COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Cardiovascular status of patients with a severe form of COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 Variants of apelin gene and COPD Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma Year: 2016 A multimarker approach to identify atherosclerosis in COPD Source: International Congress 2014 – Markers Year: 2014 COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Lung function in never smoking patients with alpha1antitrypsin deficiency Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Features of systemic inflammation in patients with stable COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Proteinase-inhibitor system state in patients with COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Is there a strong relationship between COPD and cardiovascular diseases? Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013 Hypogonadism as a factor influencing health condition in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Relationship between gene polymorphism in FGF10 and susceptibility to 220 patients with COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 The effect of smoking on the activity of inflammatory markers in patients with COPD Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013